HIGHLIGHT
Lidocaine Infusions and Other Options for Opioid-Resistant Pain Due to Pediatric Advanced Cancer
Charles Berde MD, PhD,
Corresponding Author
Charles Berde MD, PhD
Division of Pain Medicine, Department of Anesthesiology, Perioperative and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts
Department of Anaesthesia, Harvard Medical School, Boston, Massachusetts
Correspondence to: Charles Berde, Division of Pain Medicine, Department of Anesthesiology, Perioperative and Pain Medicine, Boston Children's Hospital, 333 Longwood Ave 5th floor, Boston, MA 02115. E-mail: [email protected]
Search for more papers by this author Anjali Koka MD,
Anjali Koka MD
Division of Pain Medicine, Department of Anesthesiology, Perioperative and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts
Department of Anaesthesia, Harvard Medical School, Boston, Massachusetts
Search for more papers by this author Carolina Donado-Rincon MD,
Carolina Donado-Rincon MD
Division of Pain Medicine, Department of Anesthesiology, Perioperative and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts
Search for more papers by this author
Charles Berde MD, PhD,
Corresponding Author
Charles Berde MD, PhD
Division of Pain Medicine, Department of Anesthesiology, Perioperative and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts
Department of Anaesthesia, Harvard Medical School, Boston, Massachusetts
Correspondence to: Charles Berde, Division of Pain Medicine, Department of Anesthesiology, Perioperative and Pain Medicine, Boston Children's Hospital, 333 Longwood Ave 5th floor, Boston, MA 02115. E-mail: [email protected]
Search for more papers by this author Anjali Koka MD,
Anjali Koka MD
Division of Pain Medicine, Department of Anesthesiology, Perioperative and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts
Department of Anaesthesia, Harvard Medical School, Boston, Massachusetts
Search for more papers by this author Carolina Donado-Rincon MD,
Carolina Donado-Rincon MD
Division of Pain Medicine, Department of Anesthesiology, Perioperative and Pain Medicine, Boston Children's Hospital, Boston, Massachusetts
Search for more papers by this author
First published: 15 April 2016
No abstract is available for this article.
REFERENCES
- 1Collins J, Berde C, Frost J. Pain assessment and management. In: J Wolfe, PS Hinds, BM Sourkes, editors. Textbook of interdisciplinary pediatric palliative care. Philadelphia, PA: Elsevier Saunders; 2011. p. 284–299.
- 2Collins JJ, Grier HE, Kinney HC, Berde CB. Control of severe pain in children with terminal malignancy. J Pediatr 1995; 126: 653–657.
- 3Gibbons K, DeMonbrun A, Beckman E, Keefer P, Wagner D, Stewart M, Saul D, Hakel S, Liu M, Niedner M. Continuous lidocaine infusions to manage opioid-refractory pain in a series of cancer patients in a pediatric hospital. Pediatr Blood Cancer 2016; 63: 1168–1174.
- 4Bredlau AL, Thakur R, Korones DN, Dworkin RH. Ketamine for pain in adults and children with cancer: A systematic review and synthesis of the literature. Pain Med 2013; 14: 1505–1517.
- 5Finkel JC, Pestieau SR, Quezado ZMN. Ketamine as an adjuvant for treatment of cancer pain in children and adolescents. J Pain 2007; 8: 515–521.
- 6Collins JJ, Grier HE, Sethna NF, Wilder RT, Berde CB. Regional anesthesia for pain associated with terminal pediatric malignancy. Pain 1996; 65: 63–69.
- 7Rork JF, Berde CB, Goldstein RD. Regional anesthesia approaches to pain management in pediatric palliative care: A review of current knowledge. J Pain Symptom Manage 2013; 46: 859–873.
- 8Berde CB, Wolfe J. Pain, anxiety, distress, and suffering: Interrelated, but not interchangeable. J Pediatr 2003; 142: 361–363.
- 9Saunders C, The treatment of intractable pain in terminal cancer. Proc R Soc Med 1963; 56: 195–197.
- 10Brose WG, Cousins MJ. Subcutaneous lidocaine for treatment of neuropathic cancer pain. Pain 1991; 45: 145–148.
- 11Nathan A, Rose JB, Guite JW, Hehir D, Milovcich K. Primary erythromelalgia in a child responding to intravenous lidocaine and oral mexiletine treatment. Pediatrics 2005; 115: e504–e507.
- 12Wallace MS, Lee J, Sorkin L, Dunn JS, Yaksh T, Yu A. Intravenous lidocaine: Effects on controlling pain after anti-GD2 antibody therapy in children with neuroblastoma—A report of a series. Anesth Analg 1997; 85: 794–796.
- 13Massey GV, Pedigo S, Dunn NL, Grossman NJ, Russell EC. Continuous lidocaine infusion for the relief of refractory malignant pain in a terminally ill pediatric cancer patient. J Pediatr Hematol Oncol 2002; 24: 566–568.
- 14Mooney JJ, Pagel PS, Kundu A. Safety, tolerability, and short-term efficacy of intravenous lidocaine infusions for the treatment of chronic pain in adolescents and young adults: A preliminary report. Pain Med 2014; 15: 820–825.
